1,701
Views
1
CrossRef citations to date
0
Altmetric
Short Report

Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria

, , , , &
Pages 2738-2741 | Received 05 Jun 2017, Accepted 28 Jul 2017, Published online: 20 Oct 2017

References

  • Tiwari T. Diphtheria. Centers for Disease Control and Prevention. In: Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: Centers Dis Control Prevention. 2008.
  • Sane J, Sorvari T, Widerström M, Kauma H, Kaukoniemi U, Tarkka E, Puumalainen T, Kuusi M, Salminen M, Lyytikäinen O. Respiratory diphtheria in an asylum seeker from Afghanistan arriving to Finland via Sweden, December 2015, pp. 14-17. Eurosurveillance [Internet] 2016 [ cited 2016 May 12];21. Available from: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId = 21348. doi:10.2807/1560-7917.ES.2016.21.2.30105. PMID:26840007
  • UNICEF Supply Division. Diphtheria anti-toxin: market update [Internet]. 2017 [ cited 2017 Mar 10]. Available from: https://www.unicef.org/supply/files/Diphtheria_Antitoxin_Market_Update.pdf
  • Besa NC, Coldiron ME, Bakri A, Raji A, Nsuami MJ, Rousseau C, Hurtado N, Porten K. Diphtheria outbreak with high mortality in northeastern Nigeria. Epidemiol Infect. 2013;142:1-6. PMID:24093495
  • Sein C, Tiwari T, Macneil A, Wannemuehler K, Soulaphy C, Souliphone P, Reyburn R, Ramirez Gonzalez A, Watkins M, Goodson JL. Diphtheria outbreak in Lao People's Democratic Republic, 2012–2013. Vaccine. 2016;34:4321-6. doi:10.1016/j.vaccine.2016.06.074. PMID:27422343
  • European Centre for Disease Prevention and Control. Rapid risk assessment: a fatal case of diphtheria in Belgium. 2016 [ cited 2016 Nov 30]; Available from: http://ecdc.europa.eu/en/publications/Publications/RRA-Diphtheria-Belgium.pdf
  • Both L, White J, Mandal S, Efstratiou A. Access to diphtheria antitoxin for therapy and diagnostics. Euro Surveill. 2014;19:20830. doi:10.2807/1560-7917.ES2014.19.24.20830. PMID:24970373
  • Centers for Disease Control and Prevention (CDC). Use of Diphtheria Antitoxin (DAT) for Suspected Diphtheria Cases BB IND 11184. 2014 [ cited 2017 Mar 10]; Available from: http://www.cdc.gov/diphtheria/downloads/protocol.pdf
  • Smith HL, Cheslock P, Leney M, Barton B, Molrine DC. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria anti-toxin in a guinea pig intoxication model. Virulence. 2016;7:660-8. doi:10.1080/21505594.2016.1171436. PMID:27070129
  • Kakita M, Takahashi T, Komiya T, Iba Y, Tsuji T, Kurosawa Y, Takahashi M. Isolation of a Human Monoclonal Antibody with Strong Neutralizing Activity against Diphtheria Toxin. Infect Immun. 2006;74:3682-3. doi:10.1128/IAI.01731-05. PMID:16714603
  • Kupferschmidt K. Life-saving diphtheria drug is running out. Science. 2017;355:118-9. doi:10.1126/science.355.6321.118. PMID:28082541
  • American Academy of Pediatrics. Diphtheria. In: Kimberlin, DW, Brady, MT, Jackson, MA, Long, SS, ed. Red Book: 2015 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2015. pp. 325-329.
  • U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for Industry: Population Pharmacokinetics. 1999
  • Bermejo-Martin JF, Avila-Alonso A, González-Rivera M, Tamayo E, Eiros JM, Almansa R. Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin. Emerg Infect Dis. 2016;22:1265-7. doi:10.3201/eid2207.151670. PMID:27314309
  • Madsen E. The course of the passive immunity after treatment with anti-diphtheria horse serum in rabbits and in man (preliminary report). Acta Pathol Microbiol Scand. 1936;13:103-116.
  • Opinel A, Trohler U, Gluud C, Gachelin G, Davey Smith G, Podolsky SH, Chalmers I. Commentary: The evolution of methods to assess the effects of treatments, illustrated by the development of treatments for diphtheria, 1825–1918. Int J Epidemiol. 2013;42:662-76. doi:10.1093/ije/dyr162. PMID:22253300
  • Hatheway CH, Snyder JD, Seals JE, Edell TA, Lewis GE. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis 1984;150:407-12. doi:10.1093/infdis/150.3.407. PMID:6481185
  • The United States Pharmacopeial Convention. Diphtheria antitoxin potency testing for human immune globulins. In: U.S. Pharmacopoeia –National Formulary [USP 40 NF 35]. Rockville, MD: United States Pharmacopeial Convention, Inc; 2017. p. 239-241.
  • Council of Europe. Diphtheria antitoxin. In: European Pharmacopoeia 6.0. Strasbourg: Council of Europe; 2008. p. 965-966.
  • Hatheway CH, Snyder JD, Seals JE, Edell TA, Lewis GE. Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E. J Infect Dis 1984; 150:407-12. doi:10.1093/infdis/150.3.407. PMID:6481185